Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid-Reference-Cited by-同舟云学术

Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid

Published:2013-10-17 Issue:3 Volume:21 Page:221-232
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Dalpiaz Alessandro,Contado Catia,Mari Lara,Perrone Daniela,Pavan Barbara,Paganetto Guglielmo,Hanuskovà Miriam,Vighi Eleonora,Leo Eliana

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10717544.2013.844744

Reference38 articles.

1. PLGA Nanoparticles in Drug Delivery: The State of the Art;

2. Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers

3. Cell Biology of HIV-1 Infection of Macrophages

4. Solanum tuberosumlectin-conjugated PLGA nanoparticles for nose-to-brain delivery:in vivoandin vitroevaluations

5. The determination of polyethylene glycol in gamma globulin solutions

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring biomaterials for vaccine delivery;Journal of Nanobiotechnology;2024-08-12

2. Effect of ursodiol on alginate/PLL nanoparticles with non-ionic surfactant for gene delivery;Journal of Nanoparticle Research;2024-02-20

3. Amelioration of Acute Alcoholic Liver Injury via Attenuating Oxidative Damage and Modulating Inflammation by Means of Ursodeoxycholic Acid–Zein Nanoparticles;Journal of Agricultural and Food Chemistry;2023-10-31

4. Anti‐Epileptic Drug‐Lipid Conjugates for Delivery to the Brain: In Silico ADMET Prediction, Molecular Docking and Molecular Dynamics Simulations;ChemistrySelect;2023-09-08

5. Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date;Pharmaceutics;2022-04-11